AI-Enhanced DBT Is Emerging as a Tool for Hard-to-See Invasive Lobular Breast Cancer
Adjunctive AI is being explored as a way to improve digital breast tomosynthesis detection of invasive lobular carcinoma, a subtype that can be difficult to identify on standard imaging. The work highlights how AI may help radiologists see more clearly in cancer types that often blend into surrounding tissue.
Invasive lobular carcinoma remains a diagnostic challenge because it does not always form the classic mass-like appearance radiologists expect. That makes it a strong candidate for AI augmentation: if algorithms can detect patterns that human readers miss, they may improve sensitivity without requiring entirely new scanners or workflows.
The promise here is practical. Digital breast tomosynthesis is already used in many breast imaging settings, so an AI layer that improves interpretation could be easier to adopt than a wholly new modality. The key question is whether the gain is meaningful enough to justify added complexity, especially when breast imaging programs are already balancing recall rates, throughput, and patient anxiety.
This kind of adjunctive model also reflects a broader trend in medical AI: the most valuable systems may not replace existing clinical infrastructure but make it smarter. That matters because radiology adoption often depends less on novelty and more on whether a tool can fit into an established reading workflow.
If validated prospectively, AI-assisted DBT could become one of the more important examples of precision imaging support in breast cancer. The larger implication is that AI may be especially useful where the disease is biologically subtle rather than visually obvious.